Tech Company Financing Transactions
Tortugas Neuroscience Funding Round
On 4/21/2026, Tortugas Neuroscience announced $106 million in funding from Cure Ventures and The Column Group.
Transaction Overview
Company Name
Announced On
4/21/2026
Transaction Type
Venture Equity
Amount
$106,000,000
Round
Undisclosed
Investors
Cure Ventures (Lead Investor)
Proceeds Purpose
The company intends to use the funds to support ongoing research and development initiatives, including the completion of Phase 2 clinical trials for its two lead candidates.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
349 Newbury Street, 2nd Floor
Boston, MA 02115
USA
Boston, MA 02115
USA
Phone
Undisclosed
Website
Email Address
Overview
We are a next-generation neuroscience company committed to transforming the future of brain health. Guided by visionary leadership, supported by strong financial partners, and powered by cutting-edge science, we are advancing innovative therapies designed to change the lives of people affected by neurological disorders. Our approach is bold yet deeply human--combining world-class research with an unwavering focus on patient needs. By uniting scientific rigor, curiosity, and collaboration, we aim to unlock new frontiers in understanding the brain and deliver solutions once thought impossible.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeff Jonas
Chief Financial Officer
Drew King
President
Albert Robichaud
VP - Bus. Development
Richard Lim
Browse more venture capital transactions:
Prev: 4/21/2026: Reliable Robotics venture capital transaction
Next: 4/21/2026: Smart Robotics venture capital transaction
Share this article
News on VC Transactions
We do our best to report on tech company VC transactions. VC investment data records on this site are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs